Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Obesity Drug Stocks Go Wild After Belviq Approval
Investors.com
Thursday, June 28, 2012 - 6:14pm
tags:
obesity, lorcaserin, Belviq, Arena Pharmaceuticals, Orexigen, Vivus
Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat
Yahoo
Thursday, June 28, 2012 - 6:13pm
tags:
FDA, Gilead, cobicistat
What The Supreme Court Ruling Means For Pharma
Forbes
Thursday, June 28, 2012 - 6:05pm
tags:
healthcare reform, Supreme Court
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Thursday, June 28, 2012 - 6:04pm
tags:
Astellas, FDA, overactive bladder, mirabegron
Merck's $303 Million Ambryx Deal Great For Investors
Seeking Alpha
Thursday, June 28, 2012 - 6:03pm
tags:
Merck, Ambryx, AstraZeneca, GSK, Novartis, Pfizer, Palatin
Why ViroPharma May Be About to Take Off
Motley Fool
Thursday, June 28, 2012 - 12:53pm
tags:
ViroPharma
Vertex shares drop 11% on CF drug study
Marketwatch
Thursday, June 28, 2012 - 12:52pm
tags:
Vertex Pharmaceuticals, cystic fibrosis, VX-809
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thursday, June 28, 2012 - 12:49pm
tags:
GSK, Biomarin, M&A, Shire
Anthera plunges on drug study
Marketwatch
Thursday, June 28, 2012 - 12:47pm
tags:
Anthera, blisibimod, lupus
Shire Seen Luring Pfizer To Teva With Lowest Valuation: Real M&A
Bloomberg
Thursday, June 28, 2012 - 12:46pm
tags:
Shire, Pfizer, Teva Pharmaceuticals, M&A
Big Pharma Stocks Hold Steady after Health Care Ruling
Barron's
Thursday, June 28, 2012 - 12:45pm
tags:
healthcare reform
Supreme Court upholds health-care law, individual mandate
Washington Post, DC
Thursday, June 28, 2012 - 10:50am
tags:
Supreme Court, healthcare reform, insurance
Janssen Acquires Corimmun
Marketwatch
Thursday, June 28, 2012 - 10:48am
tags:
Janssen, JNJ, M&A, Corimmun
Prolor Biotech Receives A Boost On Data Presentation
Seeking Alpha
Thursday, June 28, 2012 - 10:46am
tags:
Prolor, hGH-CTP, Merck
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
Thursday, June 28, 2012 - 10:31am
tags:
asthma, AstraZeneca, Rigel, JAK inhibitors, Amgen, GSK, JNJ, Eli Lilly, Merck, R256
Arena’s Weight-Loss Pill Approved By U.S. Regulators
Bloomberg
Wednesday, June 27, 2012 - 4:33pm
tags:
Arena, obesity, FDA, lorcaserin, Belviq
IPO Preview: Tesaro
Seeking Alpha
Wednesday, June 27, 2012 - 4:32pm
tags:
IPOs, Tesaro
Cornerstone Therapeutics buys IV blood pressure drug maker EKR in deal worth up to $150M
Yahoo/AP
Wednesday, June 27, 2012 - 12:46pm
tags:
Cornerstone Therapeutics, EKR Therapeutics, M&A
MenHibrix: GlaxoSmithKline Pharmaceuticals' Shot In The Arm
Seeking Alpha
Wednesday, June 27, 2012 - 12:44pm
tags:
MenHibrix, GSK, Merck, Novartis, Pfizer, Sanofi
Psivida: Small-Cap Ophthalmology-Based BioTech Positioned For Long-Term Growth
Yahoo/Reuters
Wednesday, June 27, 2012 - 12:41pm
tags:
pSivida, ophthalmology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.